Juno jumps and falls on clinical trial news, but the recent news has not implied anything about the company's drug itself. If you are afraid Juno will see more snags before the trial completes, stay ...

SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (Nasdaq: JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced ...

SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced ...

It was a clear, calm night at Cape Canaveral. The Army, making its first attempt to shoot the moon, had spent weeks fussing over the Juno II, a 60-ton Jupiter IRBM with a spike of high-speed rockets ...

* Juno - one patient died and as of tuesday night other is not expected to recover. * Juno says company is assessing data from cases and trial and is evaluating its options regarding jcar015 program * ...